Cargando…
Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA
The increasing antibiotic resistance evolved by Helicobacter pylori has alarmingly reduced the eradication rates of first-line therapies. To overcome the current circulating resistome, we selected a novel potential therapeutic target in order to identify new candidate drugs for treating H. pylori in...
Autores principales: | González, Andrés, Salillas, Sandra, Velázquez-Campoy, Adrián, Espinosa Angarica, Vladimir, Fillat, María F., Sancho, Javier, Lanas, Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683298/ https://www.ncbi.nlm.nih.gov/pubmed/31383920 http://dx.doi.org/10.1038/s41598-019-47746-9 |
Ejemplares similares
-
Repurposing Dihydropyridines for Treatment of Helicobacter pylori Infection
por: González, Andrés, et al.
Publicado: (2019) -
Small Molecule Inhibitors of the Response Regulator ArsR Exhibit Bactericidal Activity against Helicobacter pylori
por: González, Andrés, et al.
Publicado: (2020) -
1,4-Dihydropyridine as a Promising Scaffold for Novel Antimicrobials Against Helicobacter pylori
por: González, Andrés, et al.
Publicado: (2022) -
Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens
por: Salillas, Sandra, et al.
Publicado: (2020) -
The FurA regulon in Anabaena sp. PCC 7120: in silico prediction and experimental validation of novel target genes
por: González, Andrés, et al.
Publicado: (2014)